(Q34644974)

English

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute coronary syndrome

1 reference

based on heuristic

inferred from title

Thomas Lüscher

13

object named as

Thomas F Lüscher

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Wolfgang Koenig

10

object named as

Wolfgang Koenig

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

John J. P. Kastelein

7

object named as

John J P Kastelein

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Emmanouil S. Brilakis

1 reference

ORCID Public Data File 2021

Christie M. Ballantyne

2

object named as

Christie M Ballantyne

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jean-Claude Tardif

1

object named as

Jean-Claude Tardif

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Marie-Claude Guertin

6

object named as

Marie-Claude Guertin

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Philip Barter

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jean-Louis Dasseux

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Zahi A Fayad

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Constance Keyserling

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Heather Klepp

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Philippe L L'Allier

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jacques Lespérance

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

John F Paolini

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ahmed Tawakol

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

David D Waters

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Can HDL Infusions Significantly QUicken Atherosclerosis REgression (CHI-SQUARE) Investigators

17

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

29 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3277-3286

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

7 July 2018

High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality

2 references

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU171

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

26 October 2018

Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU171

21 January 2018

Effects of AGI-1067 and probucol after percutaneous coronary interventions.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU171

21 January 2018

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU171

21 January 2018

Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU171

21 January 2018

Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU171

21 January 2018

Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4258222

26 October 2018

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24780501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24780501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/24780501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24780501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/EURHEARTJ/EHU171

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34644974&oldid=1993064396"